TFO
ICPT

Tarbox Family Office’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Tarbox Family Office’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13
Closed -$1K – 1272
2020
Q1 		$1K Buy
+13
New +$1.17K ﹤0.01% 1049

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Tarbox Family Office's ICPT Position: Q2 2020 in Review

Tarbox Family Office sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2020, closing a stake of 13 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in ICPT in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

  • Tarbox Family Office reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Tarbox Family Office sold 13 Intercept Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1K.
  • Tarbox Family Office first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2020 and held it in 1 quarter.
  • Tarbox Family Office's Intercept Pharmaceuticals, Inc. position peaked at $1K in Q1 2020.
  • 192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on Tarbox Family Office's 13F filing for Q2 2020, filed 23 Jul 2020.